New Zealand markets closed

Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi (MEDTR.IS)

Istanbul - Istanbul Delayed price. Currency in TRY
Add to watchlist
35.06+0.08 (+0.23%)
At close: 06:08PM TRT
Currency in TRY

Valuation measures4

Market cap (intra-day) 4.17B
Enterprise value 3.83B
Trailing P/E 159.36
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.87
Price/book (mrq)2.83
Enterprise value/revenue 2.64
Enterprise value/EBITDA 23.86

Trading information

Stock price history

Beta (5Y monthly) 0.56
52-week change 3-10.19%
S&P500 52-week change 322.55%
52-week high 347.66
52-week low 324.34
50-day moving average 332.41
200-day moving average 334.65

Share statistics

Avg vol (3-month) 3734.38k
Avg vol (10-day) 3517.25k
Shares outstanding 5119M
Implied shares outstanding 6119M
Float 824.45M
% held by insiders 179.45%
% held by institutions 10.42%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.29
Forward annual dividend yield 40.84%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4572.96%
Dividend date 3N/A
Ex-dividend date 423 Oct 2024
Last split factor 2350:100
Last split date 322 Feb 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 5.83%
Operating margin (ttm)22.80%

Management effectiveness

Return on assets (ttm)11.85%
Return on equity (ttm)6.72%

Income statement

Revenue (ttm)1.5B
Revenue per share (ttm)12.60
Quarterly revenue growth (yoy)12.30%
Gross profit (ttm)N/A
EBITDA 372.6M
Net income avi to common (ttm)87.48M
Diluted EPS (ttm)0.22
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)369.46M
Total cash per share (mrq)3.11
Total debt (mrq)76M
Total debt/equity (mrq)4.41%
Current ratio (mrq)3.75
Book value per share (mrq)14.42

Cash flow statement

Operating cash flow (ttm)-4.94M
Levered free cash flow (ttm)-363.28M